Eli Lilly and Co (LLY.HM)
Hamburg - Hamburg Delayed price. Currency in EUR
Add to watchlist
At close: 05:25PM CEST
| Previous close | 836.40 |
| Open | 830.90 |
| Bid | 0.00 x 0 |
| Ask | 0.00 x 0 |
| Day's range | 830.90 - 842.10 |
| 52-week range | 516.50 - 882.00 |
| Volume | |
| Avg. volume | 36 |
| Market cap | N/A |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | 30 Oct 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
Simply Wall St.Boasting A 54% Return On Equity, Is Eli Lilly and Company (NYSE:LLY) A Top Quality Stock?
One of the best investments we can make is in our own knowledge and skill set. With that in mind, this article will...
Insider MonkeyEli Lilly and Company (LLY): Among the Most Promising Growth Stocks According to Hedge Funds
We recently compiled a list of the 10 Most Promising Growth Stocks According to Hedge Funds. In this article, we are going to take a look at where Eli Lilly and Company (NYSE:LLY) stands against the other Most Promising Growth Stock According to Hedge Funds. Bull Market and Investor Sentiment Investors had been anxiously anticipating the start […]
GuruFocus.comEli Lilly Expects Zepbound Approval in Japan by Mid-2025, Eyes Weight-Loss Market
Eli Lilly anticipates regulatory approval for its weight-loss drug Zepbound in Japan by mid-2025, boosting its global portfolio
© 2024 Yahoo. All rights reserved.